Skip to main content

Table 2 Risk factor differences in age groups

From: Recombinant human Bone Morphogenetic Protein-2 (rhBMP-2) in posterolateral lumbar spine fusion: complications in the elderly

Contributing factors

Group 1

Group 2

Significance

 

(18-64 years)

(≥65 years)

 
 

N=250

N=232

 

Gender

  

χ²=0.292

male

111 (44.4%)

92 (39.7%)

 

female

139 (55.6%)

140 (60.3%)

 

BMI(kg/m²)

32.2a (18.4-63.9)

30.5 (18.5-57.2)

p=0.006

Diabetes

35 (14.0%)

49 (21.1%)

χ²=0.109

Cardiovascular disease

114 (45.6%)

147 (63.4%)

χ²<0.001

Respiratory disease

58 (23.2%)

40 (17.2%)

χ²=0.104

Current Tobacco Use

51 (20.4%)

6 (2.6%)

χ²<0.001

Allergies

121 (52.6%)

97 (46.0%)

χ²=0.234

Steroid medication

53 (21.2%)

68 (29.3%)

χ²=0.081

Preoperative NSAID

83 (37.7%)

107 (46.1%)

χ²=0.010

Previous BMP exposure

10 (4.0%)

8 (3.4%)

χ²=0.740

  1. BMI=Body Mass Index, BMP=Bone morphogenetic protein, NSAID= non-steroidal anti-inflammatory drugs.